Cervical cancer has been associated with specific human leukocyte antigen (HLA) haplotypes/alleles and with polymorphisms at the nearby non-HLA loci TNF, LTA, TAP1 and TAP2. Distinguishing effects of individual loci in the major histocompatibility complex (MHC) region are difficult due to the complex linkage disequilibrium (LD) pattern characterized by high LD, punctuated by recombination hot spots. We have evaluated the association of polymorphism at HLA class II DQB1 and the TNF, LTA, TAP1 and TAP2 genes with cervical cancer risk, using 1306 familial cases and 288 controls. DQB1 was strongly associated; alleles *0301, *0402 and *0602 increased cancer susceptibility, whereas *0501 and *0603 decreased susceptibility. Among the non-HLA loci, association was only detected for the TAP2 665 polymorphism, and interallelic disequilibrium analysis indicated that this could be due to LD with DQB1. As the TAP2 665 association was seen predominantly in non-carriers of DQB1 susceptibility alleles, we hypothesized that TAP2 665 may have an effect not attributable to LD with DQB1. However, a logistic regression analysis suggested that TAP2 665 was strongly influenced by LD with DQB1. Our results emphasize the importance of large sample sizes and underscore the necessity of examining both HLA and non-HLA loci in the MHC to assign association to the correct locus.
Introduction
Cervical cancer is the second most common cancer among women worldwide with 471 000 cases and 233 000 deaths each year. 1 Infection by an oncogenic type of human papillomavirus (HPV) is a necessary but not sufficient risk factor for cervical cancer development. 2 A genetic predisposition to cervical cancer is indicated by the observation that biological, but not non-biological, first-degree relatives of women diagnosed with cervical tumor experience a doubled risk of tumor development. 3 It is likely that genetic risk factors for cervical cancer reflect genetic variation influencing the immune response toward HPV infection. Consequently, a number of genes involved in inflammation and immunity have been suggested to contribute to cervical cancer susceptibility.
The immune response toward peptide antigens is mediated by proteins encoded by genes in the major histocompatibility complex (MHC). The MHC region harbors genes encoding the human leukocyte antigen (HLA) class I and II molecules, as well as genes encoding other proteins involved in peptide display, the complement system and cytokines. Cervical cancer has been linked to the HLA class II region, 4 and a summary of association studies showed that DQB1*03 increased susceptibility in 16 of 27 studies, the DRB1*1501/DQB1*0602 haplotype increased susceptibility in 9 of 21 and DQB1*0603 decreased the susceptibility in 18 of 19 studies. 5 In the Swedish population, previous studies demonstrate significant association only with DQB1*0602. This allele has been associated with cervical intraepithelial neoplasia 6 and cancer in situ in HPV16-positive women 7 as well as with invasive cervical cancer. 8 Apart from the HLA genes, polymorphisms in genes encoding the two cytokines tumor necrosis factor (TNF, also called TNFa or cachectin) and lymphotoxin-alpha (LTA, also known as TNFb), both located in the MHC class III region, and the transporter associated with antigen processing 1 and 2 (TAP1 and TAP2) have been associated with cervical cancer susceptibility. Both tumor and stromal cells in the microenvironment of many tumors chronically produce low levels of TNF. 9 Some studies have shown TNF levels in the cervix to be higher in cervical cancer patients 10 and patients with high-grade lesions. 11 Other studies have been contradictory, either showing TNF to increase 12 or decrease 13 the expression of HPV16 E6/E7 RNAs, and to stimulate or suppress proliferation of transformed cervical cell lines or carcinoma cell lines. 14, 15 Numerous studies have evaluated TNF as a candidate gene for cervical cancer susceptibility. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Most studies of TNF as a risk factor for cervical cancer have focused on the -238 and -308 promoter single nucleotide polymorphisms (SNPs). For -238, three of five studies show a protective effect of the A allele 16, 21, 23 and two studies report no association, 17, 24 whereas for -308, six of eight studies showed no association, 16, 17, [21] [22] [23] 25 and one study reports an association of the A allele with risk 18 and another study associates the G allele with risk. 24 The TNFa microsatellite, located in the TNF region of MHC class III, showed no association to disease, but the TNFa-11 allele was associated with cervical intraepithelial neoplasia and invasive cervical cancer in Swedish carriers of DQB1*0602. 19, 20 In an analysis of 11 SNPs in the TNF, two SNPs in the promoter region showed an association in HPV16-infected Hispanic cervical cancer patients, and one SNP showed an association in non-Hispanic whites. 17 In the LTA gene, two polymorphisms, C804A and A252G, which are in complete linkage disequilibrium (LD), have shown a protective effect that is stronger in squamous cell carcinoma than in adenocarcinoma in a Japanese cohort. 26 The TAP is a heterodimer of TAP1 and TAP2 proteins, which brings cytosolic peptides to the endoplasmic reticulum lumen for association with MHC class I molecules. There are four TAP1 alleles (TAP1A-D) and at least eight TAP2 alleles (TAP2A-H). 27, 28 The functional consequences of the coding polymorphisms in the TAP1 and TAP2 genes are unclear. 29 Studies have shown loss of TAP1 expression in 37 of 76 cervical cancer cases 30 and allelic loss in tumors in 12 of 23 cases. 31 The TAP1C/C allele has shown a negative association and the TAP2A/B allele a positive association with cervical cancer. 21, 31 A recent study analyzing SNPs in HLA class I antigenprocessing genes reports association for three TAP1 SNPs and one TAP2 SNP in HPV16-positive Hispanic patients and for two TAP1 SNPs and one TAP2 SNP in nonHispanic whites. 32 The interpretation of candidate gene studies in the MHC region is complicated by the complex LD patterns, characterized by high LD over long stretches, interrupted by multiple recombination hot spots. 33, 34 Most studies on the effect of non-HLA loci on cervical cancer risk have not included nearby known risk factors in LD, such as alleles at the HLA class I and class II loci, making it essentially impossible to identify the effect of individual loci. The aim of the current study was to analyze the association of HLA-DQB1 and polymorphisms in the TNF, LTA, TAP1 and TAP2 genes, situated in the MHC region, with cervical cancer susceptibility, in an attempt to clarify whether any associations of the non-HLA genes were due to LD with DQB1.
Results
Analysis of the familial material showed that both the DQB1*0501 allele (P emp ¼ 0.04, OR: 0.72, 95% CI emp : 0.52-0.99) and the *0603 allele (P emp ¼ 0.001, OR: 0.51, 95% CI emp 0.33-0.80) decreased the risk of cervical cancer, whereas *0301 (P emp ¼ 0.02, OR: 1.45, 95% CI emp :
1.07-1.95) and *0602 (P emp ¼ 0.01, OR: 1.46, 95% CI emp : 1.09-1.94) increased the risk (Table 1) . DQB1*0402 appeared to increase risk, but the effect was not significant (P emp ¼ 0.16, OR: 1.36, 95% CI emp : 0.88-2.10). These results were strengthened when the material was analyzed together with a previously studied, independent data set from the same population 7 using Cochran-Mantel-Haenszel statistics ( Table 1 All SNPs were successfully typed in 497% of the samples and there was no departure from the HardyWeinberg equilibrium. Analysis of the SNPs in TNF, LTA, TAP1 and TAP2 under the additive model using the Cochran-Armitage test for trend indicated a difference in genotype distribution only for TAP2 665 polymorphism (P trend ¼ 0.019) ( Table 2 ). The frequency of the TAP2 665 nucleotide allele T was higher in cases than in controls (0.801 vs 0.756, P ¼ 0.018) and this difference was significant after correction for family structure, using PedGenie (P emp ¼ 0.024), but not when adjusted for multiple comparisons using 100 000 permutations in HaploView.
The inferred haplotypes agreed well with those previously reported (Table 3) . Haplotype frequencies did not differ between cases and controls, using 100 000 permutations in HaploView. An excess of TAP2A/TAP2B heterozygotes has previously been reported in cervical cancer patients. 21, 31 In our material, 1262 cases and 273 controls were successfully genotyped for all TAP2 polymorphisms, and the frequency of TAP2A/TAP2B heterozygotes was 19.3% in cases and 20.9% in controls, that is no difference was detected.
HaploView showed an LD pattern that was quite variable across the region. LD was strong between LTA and TNF, as well as within TNF and TAP1 (Figure 1 ). Some LD was seen in TAP2, whereas there was less LD between the TAP genes, and there was no apparent LD between the LTA/TNF cluster and the TAP genes. There was moderate-to-strong LD between DQB1*0402, *0501, *0602 and *0603 alleles and the TAP2 665 SNP. Strong LD was observed between*0301 and TNF -572 and also between*0602 and *0603, and TNF -572 and TAP2 379. However, TNF -572 showed only limited polymorphism in this material. Analyses of the interallelic disequilibrium between DQB1 and TAP2 665 revealed that the T allele, associated with increased risk, occurred together with the DQB1 risk alleles *0402 and *0602 more often than expected by the allele frequencies ( Table 4 ). The C allele, associated with decreased risk, was found with the protective alleles *0501 and *0603. This interallelic LD pattern implies that the association of TAP2 665 with cervical cancer could be due to hitchhiking with DQB1.
To understand whether the association of TAP2 665 with cervical cancer was caused by hitchhiking with DQB1 or a separate effect, we stratified the material based on positivity for each of the DQB1 alleles associated with increased (*0301, *0402 and *0602) or decreased risk (*0501 and *0603) and examined the association in each strata separately ( Table 5 ). The SNP allele frequencies were significantly different between cases and controls negative for *0501 and *0602, and the differences approached significance in individuals negative for *0301 (P ¼ 0.058), *0402 (P ¼ 0.053) and *0603 (P ¼ 0.071). The fact that allele frequencies for TAP2 665 differ more among non-carriers than carriers of DQB1 alleles associated with the risk of cervical cancer suggested that the effect of TAP2 665 on cervical cancer susceptibility might be separate from that of DQB1.
Logistic regression analysis showed that the DQB1 alleles *0301, *0501, *0602 and *0603, but not *0402, had an effect on the risk of cervical cancer in our material (Table 6 ). For TAP2 665, there was a significant effect (P ¼ 0.04) when the recessive model was used but not for the other models why the recessive model was chosen for further analysis including DQB1 alleles and TAP2 665 in the model simultaneously. The combined analysis revealed that the association of DQB1 alleles *0301, *0602 and *0603 remained significant when adjusted for the effect of TAP2 665, but the association of TAP2 665 was not significant when adjusted for the DQB1 alleles. Adjustment for DQB1*0501 and *0603 seemed to have a particular influence on the TAP2 665 effect, and the effect of DQB1*0501 was no longer visible when adjusted for TAP2 665. This might reflect that LD was stronger between TAP2 665 and *0501 (D 0 : 0.717; LOD: 75.1; R 2 : 0.227) than with any of the other DQB1 alleles. The results of the logistic regression confirmed that the associations of these loci are not independent, due to LD, and supports that the primary association is with DQB1 and not caused by TAP2 665. It was difficult to draw any conclusions regarding TAP2 665, but the fact that there was no effect of TAP2 665 when adjusted for DQB1 indicated that the TAP2 665 association might be attributable to DQB1.
Discussion
We have studied the association of variation at DQB1 and four non-HLA genes in the MHC region with susceptibility to cervical cancer. Our joint analysis clearly shows that DQB1*0402 and DQB1*0602 increase the risk, whereas *0501 and *0603 decrease the risk of cervical cancer in Swedish samples. Previous studies of Swedish patient cohorts have indicated that these four alleles affect susceptibility to cervical cancer, but only *0602 reached statistical significance. [6] [7] [8] Smaller studies of other populations have also indicated a protective effect of DQB1*0501.
35-38 DQB1*0603, which is in strong LD with DRB1*1301 and DQA1* 0103, has been associated with reduced risk in many populations, 5, 38 but not in Sweden. The DQB1*0603 allele occurs at low frequency in the Swedish population and this is the first study with sufficient statistical power to detect this association. DQB1*0402, in strong LD with DRB1*0801 and DQA1*0401, has been proposed as a risk allele in some small studies of other populations, 39, 40 but the results reported here are the first demonstration of its effect. Other DQB1 alleles, such as the *03 (*0301), have shown an association in several other populations, 38 but previously no association in the Swedish population. There was no apparent difference between cases and controls for all *03 alleles taken together but when *0301 was examined separately, based on the suggestion that this allele confers most of the effect for the *03 group, 41 it seemed that *0301 was associated with susceptibility in the familial material. The association was not strengthened in the joint analysis, reflecting the fact that there was no association in the previous study. Thus, larger sample size enabled us to conclusively determine the specific association of the HLA DQB1 alleles *0402, *0501, *0602 and *0603 with cervical cancer susceptibility in the Swedish population and also suggests an association of DQB1*0301. The coding polymorphism of class II loci may affect the foreign antigen-binding specificity of the HLA molecule and thereby the immune reaction elicited toward infecting agents such as HPV. We examined the amino acid (aa) differences between DQB1 alleles that increased (*0602) and decreased (*0603) the risk of cervical cancer. There are only two aa differences between the protective *0603 and the risk allele *0602 (IMGT/HLA database release 2.20.2, 11 January 2008; http://www.ebi.ac.uk/imgt/hla/align.html 42 ). The discrepancies between *0602 and *0603 occur at aa 9 and 30, residues that contribute to pocket 6 of the class II molecule, and have been shown to influence the binding of peptides. 43, 44 These aa differences might alter the ability to present specific HPV peptides, thereby affecting the efficiency of the immune reaction against HPV. The DQB1*0602 is implicated in other diseases connected to the immune system. DQB1*0602 is associated with reduced risk of both type I diabetes 45 and severe systemic disease in invasive streptococcal infection. 46 However, differences in the DQA1 (DQA1*0102 vs *0103) and DRB1 alleles (*1501 vs *1301) on these haplotypes may also contribute to the differential effects on immune responses to HPV peptides.
Among the non-HLA loci examined, only the TAP2 665 SNP showed an allele frequency difference between cases and controls, with the T allele being associated with increased risk. This association did not remain significant after correction for multiple testing. However, as the TAP genes have previously been considered as candidate susceptibility loci, our analysis could be regarded as a replication with no correction for multiple testing required. Many previous studies have investigated the TNF À238 and À308 SNPs. [16] [17] [18] [21] [22] [23] [24] [25] The number of cases genotyped in the current investigation exceeds all previous studies taken together and we could not detect any association for these polymorphisms.
The TAP2A haplotype was somewhat more common and the TAP2B haplotype less common in cases relative to controls. These two haplotypes differ only at nucleotide position 665. Previous studies have suggested a TAP2A  TAP2B  TAP2C  TAP2D  TAP2E  TAP2F  -TAP2  TAP2 665  T  C  T  T  T  T  C  TAP2 protective effect of the TAP1C allele and increased risk associated with the TAP2A/TAP2B allele. 21, 31 The TAP1C allele was not observed in our material. The TAP2A and TAP2B alleles were common in our material, but the frequency of TAP2A/TAP2B heterozygotes did not differ between cases and controls. Recently published work by Deshpande et al. 32 report an association of the TAP1 697 SNP not replicated in our material, but did not analyze TAP2 665 due to deviation from Hardy-Weinberg equilibrium proportions. The functional implication of the polymorphisms in TAP genes is unclear. In rat, it has been shown that TAP2 polymorphisms could affect peptide transfer. 47 Human TAP genes are less polymorphic and this polymorphism does not seem to alter peptide transport. 48 The interallelic LD between TAP2 665 and the DQB1 alleles associated with cervical cancer made it difficult to exclude the possibility that the TAP2 665 association with cervical cancer was due to LD with specific alleles at HLA-DQB1. Previous studies have shown that there is no strong LD between the TAP1 and TAP2 genes or between TAP1/TAP2 and HLA class II genes in Caucasians. 49, 50 This may reflect the recombinational hot spot located in TAP2. 51 Nevertheless, certain HLA-DR-DQ haplotypes extend to include the TAP alleles 49 and there is a possibility that TAP associations with disease could reflect HLA effects; there are several reports where putative associations are dependent on HLA alleles and likely to be caused by LD with HLA genes. 27, 52, 53 To determine if the association of the TAP2 665 SNP with cervical cancer depended on DQB1, we stratified the cases and controls based on positivity for DQB1 alleles. We observed an association of TAP2 665 with cervical cancer only in the non-carrier groups for several of the DQB1 alleles. As the TAP2 665 association was seen in non-carriers of both susceptible and protective DQB1 alleles, we hypothesized that TAP2 665 might have an effect on the susceptibility to cervical cancer distinguishable from that of the DQB1 allele. However, results from logistic regression analysis supported that the DQB1 association was independent of TAP2 665, but not the opposite. We concluded that the TAP2 665 association was influenced, and perhaps caused, by LD with DQB1, but it could of course also be attributable to another functional site in LD with both loci. These results highlight the importance of examining a range of MHC loci together, rather than as independent entities, as DQB1 allele frequency differences between patients and controls may cause spurious associations of SNPs in other MHC loci due to LD. The power to detect genetic influences was increased in the current investigation by the fact that cases have a family history of cervical cancer. Still, the study would have benefited from increased sample sizes and a better balance between the number of cases and controls. Another limitation to this study was the use of blood donor controls, although these provided reasonable estimates of the baseline allele frequencies in the population. We have studied some of the most relevant MHC loci suggested to affect cervical cancer susceptibility, but there are obviously many other genes influencing the immune response toward viral infections in the MHC region and elsewhere that require examination.
G)-H1/H2 (A)-H3 (G)-H4 (A)-H5 (A)-H6 (X)-H1/H2 LTA+TNF
Our results emphasize that associations of non-HLA genes in the MHC region should be considered with caution until an appropriate adjustment for LD with HLA loci has been applied. In other diseases, such as type I diabetes, it has been shown that associations with non-HLA loci in the MHC region must be regarded as tentative, as adjusting for known HLA risk alleles alters the findings. 54 It may be hypothesized that associations with HLA class II genes are secondary and reflect other genes that are the true mediators of functionality, although the role of the class II genes in the immune response renders this hypothesis unlikely in the case of cervical cancer. Distinguishing the MHC loci that are the true functional mediators of diseases such as cervical cancer remains a challenge for the future. Our results imply that progress in this area can be made by designing studies with sufficient statistical power and by incorporating the full range of risk factors, including those previously identified.
Materials and methods

Study design
The material studied in the current investigation consisted of 1306 cases diagnosed with cervical tumors (6.8% severe dysplasia, 89.6% in situ and 3.6% invasive cervical cancer) and 288 controls. Cases were selected from families with at least two affected individuals; all had a first-degree relative (mother, sister or daughter) among the cases. These families were identified by cross-linking the Swedish Cancer Registry and the National Family Registry. 4 The 1306 cases included in this study correspond to 641 small families (617 sib-pairs, 4 families with 3 sisters and 20 families with a pair of sisters and a mother). The mean age of diagnosis was 31 years. Unrelated controls were collected among blood donors at Uppsala University Hospital. The study was approved by the regional ethical review board in Uppsala. All samples were from the Swedish population.
In addition, a previously described population-based material of 496 cases of cervical cancer in situ and 647 carefully matched controls from the same region was used for joint analysis of the DQB1 locus. 7 The mean age of diagnosis for these cases was 36 years.
The association of five HLA-DQB1 alleles (*0301, *0402, *0501, *0602 and *0603) with cervical cancer was analyzed, based on previous studies. [6] [7] [8] 38 Samples were classified as carriers (all individuals at least heterozygous for an allele) or non-carriers of each DQB1 allele. A total of 11 polymorphisms in 4 other candidate genes of the MHC were also analyzed ( Table 7) .
Genotyping
The polymorphism at the HLA class II DQB1 was typed using a linear array of immobilized sequence-specific oligonucleotide probes developed by Roche Molecular Systems (Alameda, CA, USA). Biotinylated PCR products were hybridized to the array and detected by the formation of a colored precipitate catalyzed by streptavidin-conjugated horseradish peroxidase according to previously described methods. 4, 56 Genotypes were determined by a pattern recognition algorithm implemented in StripScan (version 5.7.1; Roche Molecular Systems). The majority of the polymorphisms at non-HLA loci were genotyped using TaqMan genotyping assays (Applied Biosystems, Foster City, CA, USA) and the 7900 HT Fast Real Time PCR system (Applied Biosystems) according to the manufacturer's instructions. The polymorphism in LTA and two polymorphisms in TNF were genotyped using an assay developed by Roche Molecular Systems based on multiplex PCR and a reverse hybridization linear array with immobilized sequence-specific oligonucleotide probes, which has been previously described. 55 Genotypes were assigned by the Roche StripScan software (version 5.7.1; Roche Molecular Systems). Details regarding the SNPs studied are shown in Table 7 . Negative controls (no template) and internal reference samples were included to ascertain that genotyping was robust. The Hardy-Weinberg equilibrium was evaluated using P ¼ 0.01 as threshold.
Statistical analysis
Comparisons of cases and controls were carried out using SAS (v.9.1; SAS Institute Inc., Cary, NC, USA). For DQB1 alleles, the dominant genetic model was evaluated by comparing carrier frequencies between cases and controls using Pearson's w 2 statistics. For SNPs, the additive model was evaluated using the CochranArmitage test for trend in genotypes, and differences in allele frequencies were evaluated using Pearson's w 2 statistics. In addition, data from the present investigation was pooled with data from a previous study 7 using Cochran-Mantel-Haenszel statistics.
Using cases from a family material rather than random cases increases the power of our study to find genetic susceptibility factors. These samples are enriched for genetic influence on cervical cancer susceptibility; that is, these cases are more likely to share genetic risk factors than randomly selected sporadic cases. However, the use of related subjects may lead to inflated associations simply because of family structure. To ensure that potential associations were not caused by the familial structure of the material, PedGenie in the software Genie 2.4.2 57, 58 was used to reassess all associations that appeared significant in the primary analysis. PedGenie uses pedigree data as well as data from unrelated samples and calculates empirical P-values and confidence intervals corrected for the interrelatedness of the samples. 57 Recently, meta statistics for calculating association across studies has been incorporated in the software. 58 Pearson's w 2 and Cochran-Mantel-Haenszel statistics were calculated from N ¼ 100 000 gene-drop simulations.
The DQB1 alleles analyzed in the current study were selected on the basis of previous work pointing toward an association with cervical cancer susceptibility [6] [7] [8] 38 DQB1 association results were therefore not corrected for multiple testing and Po0.05 was considered significant. In the analysis of SNPs, uncorrected P-values were calculated for all loci as a first step. This was followed by 100 000 permutations in HaploView version 3.32 59 to obtain an adjustment for multiple comparisons in the analysis of allele frequencies (including all samples in this analysis and disregarding family structure) for SNPs displaying uncorrected Po0.05.
Haplotypes have been previously assigned for the TNF and the TAP genes. 17, 27, 28 In this study, three different sets of haplotypes were evaluated using HaploView; one haplotype covering the polymorphisms in LTA and TNF, and one covering each of TAP1 (corresponding to TAP1 alleles) and TAP2 (TAP2 alleles). In the association analysis of haplotypes, all cases from the family material were used regardless of family structure. Associations were evaluated using 100 000 permutations.
The magnitude of LD between the loci was calculated and graphically displayed by use of HaploView including all cases from the family material and controls, and performing pairwise comparisons of all markers. As HaploView is restricted to biallelic markers, DQB1 was coded as biallelic with one particular allele being investigated against all others. This was done for the alleles *0301, *0402, *0501, *0602 and *0603. LD was displayed using the standard color scheme ranging from bright red (high D 0 ) to white (low D 0 ), with blue denoting high D 0 but low LOD. MIDAS (v1.0 Multiallelic Interallelic Disequilibrium Analysis Software) 60 was used to estimate interallelic disequilibrium between TAP2 665 and DQB1 alleles in the cases from the family material. MIDAS calculates the magnitude and significance of LD between allelic combinations at two loci. To facilitate the evaluation of significance Yates's-corrected w 2 statistics were converted to P-values using 1 d.f.
The independence of the TAP2 665 and DQB1 associations was further explored using logistic regression in SAS on the familial cases and controls. The logistic regression analysis modeled the effects of DQB1 susceptibility alleles *0301, *0402, *0501, *0602 and *0603 and the SNP TAP2 665, separately or in combination, on the probability of being affected. For DQB1 alleles, the dominant model was used, and for TAP2 665 the dominant, recessive and additive models were evaluated.
